Late Breaking Abstract - Exciting phase 1 data on RESP-X, a novel monoclonal antibody targeting a key virulence mechanism of Pseudomonas aeruginosa, with potential as a treatment to reduce exacerbations in non-CF bronchiectasis - Vienna 2024

New insights in bronchiectasis

Chair(s): Antoni Torres Marti, Tony De Soyza

Session type: Oral presentation

Late Breaking Abstract - Exciting phase 1 data on RESP-X, a novel monoclonal antibody targeting a key virulence mechanism of Pseudomonas aeruginosa, with potential as a treatment to reduce exacerbations in non-CF bronchiectasis

Colm Leonard

EVENTS HOME

Previous presentation

Next presentation

Session content

Colm Leonard

Replay

Poster

Abstract

Slides

Airway eosinophilic inflammation in bronchiectasis: data from the EMBARC-BRIDGE study.

Jennifer Pollock

Replay

Abstract

Slides

Evaluation of rapid multiplex PCR for investigation of lung microbiology in bronchiectasis – preliminary data from the BRILLIANT study

Lucy Bidgood

Replay

Abstract

Slides

Cardiovascular events in patients with bronchiectasis: Data from the European Bronchiectasis Registry (EMBARC)

Benjamin Jaa Ming New

Replay

Poster

Abstract

Slides

Unveiling Cystic fibrosis in Non-CF bronchiectasis patients: Insights from the European Multicentre Bronchiectasis Audit and Research Collaboration(EMBARC) Registry

Sivagurunathan Sutharsan

Replay

Poster

Abstract

Slides

The role of microbiota in varying response to inhaled antibiotics in bronchiectasis patients with chronic Pseudomonas aeruginosa infection: a post-hoc analysis of ORBIT3 and ORBIT4

Jamie Stobo

Replay

Abstract

Slides

The international registry for primary ciliary dyskinesia reveals regional variation of genotypes and significant genotype-phenotype correlations

Johanna Raidt

Replay

Poster

Abstract

Slides

Microbial virulence in bronchiectasis: Insights from the CAMEB 2 cohort

Fransiskus Xaverius Ivan

Replay

Poster

Abstract

Slides

Sputum proteomics uncovers the heterogeneity of Pseudomonas aeruginosa infections in bronchiectasis

Rebecca C Hull

Replay

Abstract

Slides

Autologous transplantation of P63+ lung progenitor cells in patients with bronchiectasis: a randomized, single-blind, controlled trial

Wei Zuo

Replay

Abstract

Slides

Discussion and Q&A

Replay

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}